This is a news story, published by KFF Health News, that relates primarily to Donald Trump news.
For more Donald Trump news, you can click here:
more Donald Trump newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from KFF Health News, you can click here:
more news from KFF Health NewsOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
experimental drug program. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest pharmaceutical policy news, Trump campaign news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
experimental medication programKFF Health News
•
78% Informative
“Right To Try” experimental drug program saved “ thousands and thousands of lives” Former President Donald Trump has boasted in recent months about the program.
Medical experts who’ve studied the experimental treatment program say there’s no evidence to support his claims.
They say Right To Try weakened regulations intended to protect patients.
The FDA almost always approved expanded access applications, and quickly by government standards.
The FDA does not share detailed information about the number of doses provided or patients treated under Right To Try.
Trump 's claim represents an “egregious overestimate’s number of people who are using it, expert says.
The Goldwater Institute , “ The Right To Try ,” accessed Sept. 29, 2024 .
The FDA , Food and Drug Administration , Expanded Access to Investigational Drugs for Treatment Use: Questions and Answers, Guidance for Industry ,’ Nov. 2022 .
VR Score
77
Informative language
78
Neutral language
63
Article tone
formal
Language
English
Language complexity
63
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
23
Source diversity
13
Affiliate links
no affiliate links